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ABSTRACT OF THE THESIS
A Secondary Data Analysis of the Prevalence of Reported Dementia and Subjective Cognitive
Decline Across U.S. National Surveys
by
Matthew C. Picchiello
Master of Arts in Psychology
Washington University in St. Louis, 2021
Professor Brian Carpenter, Chair
Within the United States, many large-scale, nationally representative studies exist with
the goal of tracking and monitoring aspects of health. These studies are often used to establish
the prevalence of dementia and subjective cognitive decline (SCD) in the population. The goal of
the current study is to examine how different population-based studies probe respondents about
conditions related to cognitive impairment, and to assess similarities and differences in point
estimates. We reviewed eight studies and identified comparable items related to dementia and
SCD. We calculated design-appropriate point prevalence estimates and compared weighted
estimates across studies, finding a wide range and statistically significantly different estimates
for dementia (estimates ranging from 2.7% - 9.9%) and for SCD (5.6% - 46.6%). Close analysis
of item construction revealed meaningful differences in the use of terminologies and timeframes
that could account for these differences. Moreover, subtle but consequential sampling differences
were also discovered within study documentation that also could be responsible. Given the
importance of prevalence estimates for research, practice, and policy, our findings highlight the
need for harmonization across methodology in these large studies, even at their most basic level,
to establish the true burden of these conditions.
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Introduction
Dementia and subjective cognitive decline (SCD) are public health issues that affect
many people in later life. Large-scale, nationally representative health surveillance projects, such
as the Health and Retirement Study (HRS) and National Health and Nutrition Examination
Survey (NHANES), are designed to track the prevalence of cognitive health in the American
population, using a combination of objective assessments and self-reports (Clair et al., 2017).
Yet prevalence estimates of cognitive impairment within the population vary considerably
among these and similar studies (Brookmeyer et al., 2011; Prince et al., 2016). Previous research
on the prevalence of other chronic conditions obtained within these national projects also
found variability, which investigators attribute to the use of different disease definitions,
items, and research methodologies (Fahimi et al., 2008; Hsia et al., 2020). No previous studies
have specifically examined estimates regarding the prevalence of self-reported dementia and
SCD across these nationally representative studies.
There are a variety of reasons why it is important to understand the prevalence of a
disease or condition. First, policy makers use estimates to identify public health priorities, which
in turn influence workforce projections and the development of educational and training
initiatives (Noordzji et al., 2010). Second, organizations such as the National Institutes of Health,
the Centers for Disease Control, and the Alzheimer’s Association rely on prevalence estimates to
show the burden of a disease on a given population, set research priorities, and allocate research
funds (Anderson & Egge, 2014). Finally, at the level of clinical practice, prevalence estimates
help clinicians understand the base rate of a condition among their patients, which can inform
clinical decision making (Djulbegovic et al., 2014). For these reasons, obtaining reliable
and valid prevalence estimates for dementia and SCD is imperative to establish the true burden
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of these conditions in the population. Nonetheless, many nationally representative studies use
different methods to establish the prevalence of dementia and SCD, which could lead to different
estimates, with the implications outlined above for policy and practice.
Methods to Obtain Prevalence Estimates
Neuropsychological Testing
The two most often cited and influential studies that establish dementia prevalence
estimates make use of in-depth neuropsychological measures and clinical case consensus (Hebert
et al., 2013; Plassman et al., 2007). Using a sample of adults age 65 or older in the Chicago area,
Hebert and colleagues (2013) estimated 11.6% of adults reached diagnostic criteria for
Alzheimer’s disease (AD) through NINCDS-ADRDA Work Group criteria. In comparison, a
national study led by Plassman and colleagues (2007) using a subsample of the Health and
Retirement Study (HRS) estimated that 13.9% of noninstitutionalized adults over the age of 70
reached diagnostic criteria for a dementia diagnosis based on a comprehensive in-home
assessment and criteria based on the DSM-III-R and DSM-IV. Prevalence estimates generated
with standardized, objective assessments are arguably the most reliable and valid, yet even
between these two much-cited studies prevalence estimates are different, perhaps due to the
different age ranges across studies and the focus of Hebert and colleagues (2013) on AD cases
only. Moreover, replications of these findings in other nationally representative samples have
been lacking.
Brief Cognitive Testing
Other nationally representative studies conducted at a similar time have used simple
cognitive tests to ascertain dementia prevalence. These studies often show much higher
estimates. For example, using the AD8 within the nationally representative Panel Study of

2

Income Dynamics (PSID), Freedman and colleagues (2019) estimated that 21.9% of the
population over the age of 65 screened positive for dementia. Similarly, high estimates were
found within the National Social Health and Aging Project (NSHAP), which adapted the
Montreal Cognitive Assessment and found that 25.8% of older adults screened positive for mild
cognitive impairment and 15.3% for dementia (Kotwal et al., 2016). However, using the
Telephone Interview for Cognitive Status within the HRS, Langa and colleagues (2017)
estimated that 8.8% of older adults have dementia. As shown, the method of assessment can
yield very different estimates.
Moreover, one must use caution when interpreting estimates obtained with brief cognitive
screening tests given that they may overestimate rates for individuals who have lower
educational attainment or who are nonnative speakers (Skoog et al., 2017; Spering et al., 2012).
Additionally, past research has found that estimates based on brief cognitive tests performed at a
single interview may overestimate the burden of the condition, as longitudinal studies have
shown that people may qualify for a diagnosis at one wave but not another (Zissimopoulos et al.,
2018), further complicated by practice effects, even in people with mild to more severe
pathology (Gross et al., 2018).
Medicare Claims Data
One final method for establishing prevalence estimates features Medicare claims data,
which is a valuable epidemiologic tool, as they cover virtually all adults over the age of 65 in the
US, including those in both institutional and noninstitutional settings. However, these, too, show
differences in estimates depending on disease definition. For example, using a 20% random
sample of Medicare fee-for-service beneficiaries throughout the country, Koller and Bynum
(2015) estimated that 8.5% of adults above the age of 65 have a dementia subtype. More
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recently, Goodman and colleagues (2017) looked at all Medicare beneficiaries and found 14.4%
have a dementia subtype listed in their record. Here again, variations in methods (i.e., ICD-9
coding) yield substantially different dementia prevalence estimates. Moreover, some past
research has found that Medicare claims may undercount the true prevalence of dementia as
compared to more in-depth neuropsychological testing. In a study linking Aging, Demographics,
and Memory Study participants to their Medicare claims data, 14.5% of individuals were
classified as having dementia based upon neuropsychological assessment but did not have a
dementia diagnosis code within their Medicare claims record (Taylor et al., 2009).
Estimates of SCD
Estimates of SCD across studies show even wider variability than those for dementia,
likely because there is no standardized approach to measuring it. For example, a recent review
of 16 international population-based cohort studies found the prevalence of SCD ranged from
6.1% to 52.7% based on self-reports within adults over age 60 (Röhr et al., 2020), with similarly
wide estimates in US samples (van Harten et al., 2018). Moreover, an analysis by the Subjective
Cognitive Decline Initiative found little consistency in SCD items used across 19 international
studies, with 73% of items created uniquely for each individual study (Rabin et al., 2015). There
have been recent calls to harmonize measures, and researchers have recently begun to study the
impact of individual items used to create estimates, with wide methodology and ways of probing
likely causing this range.
While some nationally representative studies make use of cognitive batteries to assess the
prevalence of dementia and SCD, more common are self-report items embedded in each study.
Estimates garnered from self-report items often complement objective assessment, and they have
been shown in past research to produce prevalence estimates that are comparable to more in-
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depth case ascertainment (Bernstein & Remsburg, 2007; Griffith et al., 2020; Mulvale, 2015).
However, just as objective assessments vary from study to study, so too do self-report
items. Next, we review characteristics of these items that could contribute to differences in
prevalence estimates.
Variability in Item Construction
Although simple items in national surveys appear to be designed to ask respondents about
the same constructs (i.e., the presence of dementia and SCD), inconsistencies in terminology and
timeframe could contribute to different prevalence estimates.
Terminology
One source of variability across national studies is their use of different terminology. For
example, the Health and Retirement Study (HRS) asks if an individual has ever been diagnosed
by their doctor with “dementia, senility, or any other serious memory impairment,” while the
PSID asks a more general question about a doctor’s diagnosis of “[p]ermanent loss of memory or
loss of mental ability.” Other studies use items that ask about specific conditions, such as the
NSHAP, which asks about “Alzheimer’s disease” or “vascular dementia,” while the BRFSS and
NHANES simply discuss “conditions” which cause “problems with remembering.” Even greater
variation is found across SCD items, which ask respondents, in various ways, about basic
cognitive complaints, attention difficulties, difficulties with language, or memory concerns
(Abduulrab et al., 2008; Jessen et al., 2014). It is possible that items that use less precise
terminology (e.g., “memory loss”) may yield higher prevalence estimates than items that use
more specific terms (e.g., diagnoses of “Alzheimer disease” or “vascular dementia”).
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Timeframe
Another facet of items that may lead to variable estimates has to do with the timeframe
referenced. An item from the Midlife in the United States Study (MIDUS) study asks
participants to rate their memory over the past five years, while one from the HRS uses a 2year timeframe, and another in the NHATS only uses a single year. Past research on emotional
experiences found that when a timeframe of “last week” was used, participants inferred that
researchers were more interested in minor, more frequent events (i.e., minor experiences of
anger), whereas when the timeframe was “last year,” participants inferred that researchers were
more interested in major, infrequent events (i.e., episodes of severe anger), leading to different
reports of the severity and frequency of symptoms (Winkielman et al., 1998). Extrapolating to
items about SCD, when presented with a longer timeframe, respondents might only endorse
major changes in cognitive functioning, overlooking minor changes they would identify with a
shorter timeframe. The “peak-end rule” suggests that longer timeframes yield higher rates of
endorsement, as individuals will have a greater probability of experiencing a significant change
over that longer period (Walentynowicz et al., 2018). Conceivably, individuals will have had a
greater likelihood of cognitive decline when a longer timeframe is presented, leading them to
endorse more frequent and more severe SCD as the timeframe is longer.
Current Study
This review has pointed out several reasons why obtaining estimates of the prevalence of
dementia and SCD is difficult in survey studies, and potential reasons why there are disparate
findings. Though calls have been made to harmonize items across studies (Rabin et al., 2015),
most studies continue to use different items in their most recent waves, which will continue to
lead to different estimates. To our knowledge, no previous study has undertaken a systematic
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evaluation of methodological variation in dementia and SCD items across national studies and its
association with prevalence estimates. Therefore, the purpose of this study is to analyze the
dementia and SCD items in eight nationally representative population-based surveys. This study
has two specific aims.
First, we will examine the concordance of dementia prevalence estimates for reported
dementia and SCD across national studies. Based on previous research on other health
conditions, we expect to find significant variability across studies. Second, we will investigate
whether differences in prevalence estimates are related to differences in item terminology and
timeframe. For dementia, we hypothesize that items that incorporate more broad terminology
will receive higher endorsement. For SCD, we hypothesize that items with a longer timeframe
will yield higher prevalence estimates.
Methods
Data Sources
We identified eight U.S.-based cross-sectional and longitudinal studies with publicly
available datasets that had items related to dementia and SCD (see Table 1). In selecting studies,
we followed a similar strategy to Giovanetti and Wolf (2010). Notably, studies needed to employ
an observational design, probability-based sampling, and generate nationally representative
estimates through weighting. To control for potential time-of-measurement effects, we analyzed
data from 2013 – 2014 for most surveys, apart from the NSHAP, whose next closest wave was in
2015-2016. We reviewed each study’s fieldwork documentation and questionnaires for
dementia- and SCD-related items (see Measures) and extracted those with parallel content in at
least one other survey. We analyzed data for all individuals age 65 and above, from both selfand proxy reports when available.
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Measures
Prevalence of Reported Dementia
We defined the prevalence of dementia as indicated by an affirmative response regarding
a “condition” that impacts “remembering,” or through a self or proxy reported diagnosis made by
a doctor (see Table 2). Several of the longitudinal studies (i.e., HRS, NHATS, NSHAP, PSID)
preload data about whether a respondent reported a dementia diagnosis in a previous wave,
which is then verified with the respondent. Both previous and current reporting of dementia
indicated a positive case for our analysis. However, if a participant disputed a previous
diagnosis, they were treated as a negative case. The HRS was the only study that contained two
questions related to dementia, one asking specifically about Alzheimer’s disease (AD) and one
about other more global indicators of memory loss (such as “senility”). Respondents were first
asked about AD, and if a positive response was given, the following question on dementia was
not asked. We collapsed these items to form one variable indicating the presence of dementia to
allow for overall comparisons across studies.
Prevalence of Self-Reported Subjective cognitive decline
We identified similar self-reported items within four datasets that focused on perceptions
of one’s own cognitive functioning over time (see Table 3). As discussed in the literature review,
there was heterogeneity in SCD items, creating complications for comparisons, though we used
items with the most similar content. Since there were several different approaches taken across
studies, we broke items into two separate categories, those focusing on changes within memory
ability over a longer period, and those focused on frequency of memory problems over a
narrower period. Because response scaling options related to the severity of memory loss varied,
we collapsed items. Participants who indicated that their memory changed in a negative direction
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(e.g., responses including” worse”) were considered to have SCD. Items related to frequency
were dichotomized, with greater than normal frequency considered an endorsement of SCD
(following Taylor et al., 2018).
Demographics
Age, sex, race/ethnicity, and educational level were reported in each dataset. To allow for
comparability across each dataset, we grouped respondents into three age categories (65-74, 7584, 85+). Sex was treated as a binary variable (male, female). We grouped race/ethnicity into
three categories (non-Hispanic white, non-Hispanic black, and other races), and education into
three levels (less than high school, high school, and some college and above).
Data Analysis
Univariate and descriptive statistics were conducted using analytic weights provided
within each dataset to generate estimates for a nationally representative sample. All missing data,
including responses such as “Don’t know” or “Refused,” were excluded from our analyses. We
prepared a Complex Sample Analysis Plan and calculated prevalence estimates proportions,
standard errors, and 95% confidence intervals in SPSS (Version 27.0). We then ran pairwise
comparisons of each survey using a 2-tailed z-test, which is consistent with the method used in
previous studies that have made comparisons across national surveys (Fahimi et al., 2008; Hsia
et al., 2020). Z-test analyses were conducted in R (R Core Team, 2019). For prevalence of
dementia, we assumed a null hypothesis of equality of proportion estimates across surveys and
used a nominal α of 0.05 adjusted for multiple comparisons to determine statistically significant
differences across surveys. For SCD, we used a one-tailed z-test to determine whether longer
time frames were associated with significantly higher estimates.
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Results
Reported Prevalence of Dementia
Table 4 shows the weighted point estimates, standard errors, absolute differences, zvalues, and p-values for comparisons of self-reported dementia prevalence across studies.
Overall, dementia prevalence within the seven studies ranged considerably from 2.7% - 9.9%.
Absolute differences between studies range from 0.04% to 7.18% (mean absolute difference =
3.61%, SD = 2.23%). Differences were statistically significant across 17 of the 21 Bonferronicorrected comparisons. Of note, the prevalence in the BRFSS and NHANES, which used the
same item, were comparable (z = 0.051, p = 0.959), but significantly higher than the prevalence
estimates in every other survey. Furthermore, prevalence estimates from the NHIS and NSHAP,
the studies with the lowest estimates, did not differ from one another.
Table 5 displays reported dementia prevalence across demographic characteristics (age,
sex, race, and education) for persons over age 65 for each study. Because of the limitations
associated with conducting multiple statistical tests, we did not calculate differences across
studies for these demographic characteristics, but we have included them here as reference for
future investigators. Examining trends, here, too, prevalence estimates appear to vary widely,
and across all studies, dementia prevalence was higher with later age and lower levels of
education. Most studies showed similar trends, with higher rates in females and individuals who
did not identity as white.
Reported Prevalence of SCD
Table 6 shows the weighted point estimates, standard errors, absolute differences, zvalues, and p-values for comparisons of reported SCD across studies whose items referenced
changes in memory ability over different times frames. Nearly half (46.56%; 95% CI = 42.11 –
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51.07%) of the respondents reported SCD in the MIDUS, whose item used a 5-year time
window. Nearly one-quarter (24.34%; 95% CI = 23.41 - 25.29%) reported SCD in the HRS,
whose item used a 2-year time window. One-seventh (13.01%; 95% CI = 11.83% - 14.29%)
reported SCD in the NHATS, with its one-year window. The largest absolute difference was
between the MIDUS and the NHATS (31.23%). Consistent with our hypotheses and as evident
in Table 6, one-tailed z-tests showed higher estimate across the longer time frames.
We further assessed two items that framed self-reported SCD in terms of frequency. On
the NHANES measure that asked about SCD experiences only in the past 7 days, 5.64% (95% CI
= 4.14 - 7.64%) reported frequent problems with remembering. However, on the NHATS
measure that focused on the past month, 8.74% (95% CI = 7.75 – 9.85%) indicated frequent
problems with memory. Consistent with our earlier findings, higher rates were evident on the
item using a longer time frame, z = 3.21, p < 0.001.
Discussion
In this study, we compare prevalence rates of reported dementia and SCD across eight
prominent national surveys. Prevalence estimates ranged considerably, with a range of 2.7% 9.9% for dementia and 5.6% - 46.6% for SCD. These prevalence estimates are used for a variety
of purposes in research, practice, and policy, and the range we identified across studies has
important implications for how the burden of disease is considered. For example, if we
extrapolate our dementia percentages based on the 2010 US census, the prevalence across studies
would differ by anywhere from 1,080,040 to 3,973,580 cases. Our results point to the need for
caution when utilizing survey-based prevalence estimates and the need for consumers of these
estimates to be knowledgeable about their source.
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Although there might be several explanations for differences across studies, we highlight
notably different terminology to assess for the prevalence of dementia and SCD. Among the
dementia items analyzed, some studies inquire about specific types of dementia, while others use
more global terminology associated with cognition. For example, the PSID asks respondents
about “permanent loss of memory or mental ability.” This phrase might cover a variety of
different pathologies (e.g., stroke, multiple sclerosis, autism spectrum disorder, dementia
subtypes), thereby leading to a relatively high estimate because it encompasses several
conditions. The BRFSS and NHANES, two of the nation’s largest cross-sectional health studies,
are similarly broad, with both assessing for a “physical, mental, or emotional condition” that
inhibits “thinking, memory, or concentration.” Again, considering this kind of broad description,
other conditions such as depression or attention-deficit/hyperactivity disorder could lead to
higher endorsement rates. And although similarly broad, note the difference in wording from the
PSID. These premier studies also use a double-barreled question, which may lead to less valid
prevalence estimates (Menold, 2020). Across all our analyses, prevalence rates were significantly
higher in studies that used the most general terminology. That fact alone does not necessarily call
into the question of the prevalence estimates, but it does highlight the need for readers of these
prevalence estimates to pay close attention to how they were obtained.
The NHIS is another study whose question structure and branching logic could have an
impact on dementia estimates. The NHIS uses a two-part structure to inquire about dementia.
First, participants must affirm that they are limited on an activity of daily living, instrumental
activity of daily living, or problems associated with memory. Second, only those who endorse a
limitation are presented with a separate, open-ended question about the diseases or conditions
that cause the limitation. Conditions associated with age-related memory loss or impairment
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(such as Alzheimer’s disease) are then coded by the interviewer under the umbrella term
“senility.” This method has the potential to overlook respondents in the early stages of a
neurocognitive disorder in which function is unimpaired. The method also relies on reliable
coding by the interviewer, aggregating causes into a very diffuse and technically inaccurate
category (i.e., “senility”). The methodological idiosyncrasies of the NHIS argue for ample
caution when comparing estimates from this study.
Our item analysis also revealed that many of the studies rely on just one item, and that
one item groups many different types of dementia. This stands in contrast to the precision used to
establish the prevalence of other health conditions. For example, both the BRFSS and NSHAP
inquire about cancer generally and then probe for specific types. A similar method would be
recommended for dementia subtypes, to learn more about the burden of these lesser common
conditions.
We identified similar methodological variability regarding SCD items, which could
explain similar differences in prevalence estimates. Time frames vary widely across studies, with
items inquiring about experiences of cognitive impairment in the past week or over as many as
the past five years. Consequently, prevalence estimates vary significantly too, from about one in
20 when thinking about only the past week, to just under half of older adults when the time
frame is set at five years. As Jessen and colleagues (2014) suggest, the time frame of onset for
SCD can have predictive utility for more severe cognitive decline, but only when it is kept short.
Longer time frames have the potential to overestimate the burden of SCD and lack clinical
utility, as only a small minority will go on to develop dementia. Moreover, response options
differ as well. The severity of SCD is rated on a three-point Likert-type scale in the HRS but a
five-point Likert-type scale in the MIDUS and NHATS, making comparisons unwieldy.
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Another factor that could contribute to variation in prevalence estimates only became
apparent as we discovered some of the arcane and obscure details regarding sampling methods
across studies. Although all these studies purport to be representative of the community-based
US population, in many cases individuals with cognitive impairment are excluded from taking
the survey during recruitment, which could itself lead to skewed population prevalence
estimates. In the NSHAP, participants were excluded if the interviewer “felt the participant had
inadequate cognitive ability to complete the survey questions,” (Vasilopoulos et al., 2014, p.
S161) which could obviously deflate prevalence estimates. However, these sampling details are
not described in study documentation (i.e., field reports, technical files) that we reviewed, but
instead were revealed in a 2014 article (Vasilopoulos et al., 2014) that we uncovered after
completing our analyses and exploring potential alternative reasons for this low estimate. A
similar exclusion strategy is used in the BRFSS, although here again, this information is not
available in the publicly available study documentation and was glossed over during a training
webinar we attended. The video mentions in one sentence that interviewers are granted the
latitude to terminate their telephone conversation should they feel they are obtaining “unreliable
data” from someone with a suspected cognitive impairment (Taylor, 2021). Here again, we draw
reader’s attention to these methodological variations so that prevalence estimates can be placed
into appropriate context.
In addition to the factors outlined above, we should also mention the vulnerabilities
inherent in self- and proxy-reports of dementia and SCD. Self and proxy reports rely on
sufficient insight to identify impairment, yet awareness may be limited, and furthermore,
diagnoses of these conditions are lacking. For example, one study looking at 425 communitydwelling older adults admitted to a post-acute care unit found that nearly three-quarters (70.8%)
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reached dementia diagnostic criteria but were not diagnosed (Ferretti et al., 2010). More recently,
using a subsample of the NHATS, Amjad and colleagues (2018) found that 39.5% of older adults
with probable dementia as determined by the study’s assessment criteria did not have a
diagnosis, and 19.2% had a diagnosis that they were unaware of. Self and proxy reports also rely
on a willingness to disclose this information. Stigma and shame may inhibit acknowledging the
presence of a dementia diagnosis or memory loss (Milne, 2010), and underdiagnosis and
unawareness, especially in community samples, can also play a role (Lang et al., 2017).
Although we identified significant differences in prevalence estimates across national
studies and several factors that could contribute to those differences, our own approach has its
limitations as well. While we were methodical in reviewing hundreds of pages of study
documentation and contacted study investigators to inquire about sampling methods, it is
possible that we overlooked sampling details, and we did not get a direct response from every
study group. In addition, some studies incorporate proxy reports (HRS, NHATS) but others do
not, introducing another source of methodological variability. Previous research has identified
discordance between respondent and proxy reports (Howland et al., 2017), though proxies may
be able to provide more accurate data than individuals with more severe cognitive impairments.
Lastly, estimation of prevalence within survey data is always subject to random error, and the
differences we identified between surveys are similarly influenced by this potential error.
In conclusion, while calls have been made to harmonize SCD items across studies
(Rabins et al., 2015), large-scale studies continue to use variable methods to ascertain reported
prevalence estimates for dementia and SCD. Our study provides additional evidence of the need
to establish harmonized terminology and methods. Given that dementia is highly stigmatized,
underdiagnosed in some groups, loosely diagnosed in some settings, and vulnerable to reporting
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bias, items that inquire about a previous dementia diagnosis may be least useful in establishing
prevalence. However, if these items remain on surveys, we recommend unpacking them to learn
more about specific subtypes. In addition, we recommend two dichotomous measures on
significant changes within memory and thinking that may be useful for future studies. Note that
we call for these to be included as separate measures, and for an end to the double-barreled
approach to questioning. Lastly, we recommend that studies keep time frames short (past week,
past month) to reduce retrospective bias. Harmonizing items across studies may better harness
the strengths of national studies identifying the prevalence cognitive limitations and the true
burden of disease.
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Tables
Table 1
Population-Based Studies, Funding Agencies, Wave Analyzed and Sample Sizes
Wave
Analyzed

Total N age
65+

Type of
Respondent

Study Design
Information

Behavioral Risk
Centers for
Factor
Disease Control
Surveillance
and Prevention
System
(BRFSS)
Health &
National Institute
Retirement Study
on Aging
(HRS)

2014

158,990

Self

https://www.cdc.gov/
brfss/annual_data/an
nual_2014.html

2014

10,364

9,553 Self
811 Proxy

Midlife in the
National Institute
United States 3
on Aging
(MIDUS)
National Health
Centers for
and Nutrition
Disease Control
Examination
and Prevention
Survey
(NHANES)
National Health National Institute
and Aging
on Aging
Trends Survey
(NHATS)

2014

613

Self

2013-2014

1,306

1,276 Self
30 Proxy

https://hrsdata.isr.umi
ch.edu/dataproducts/2014-hrscore?_ga=2.2158766
31.1000590190.1613
6957531049081631.1587072
158
https://www.midus.w
isc.edu/midus3/index
.php
https://wwwn.cdc.go
v/nchs/nhanes/contin
uousnhanes/default.a
spx?BeginYear=2013

2014

4,441

3,719 Self
722 Proxy

2014

15,530

Household
Interview

2015-2016

4,377

Self

2013

1,697

Household
Interview

Survey

Funding
Agency

National Health
Centers for
Interview Survey Disease Control
(NHIS)
and Prevention
National Social National Opinion
Health and
Research Center
Aging Project
(NSHAP)
Panel Study of
Income
Dynamics
(PSID)

National Science
Foundation

https://nhats.org/rese
archer/nhats/methods
documentation?id=da
ta_collection
https://www.cdc.gov/
nchs/nhis/19972018.htm
https://www.norc.org
/Research/Projects/Pa
ges/national-sociallife-health-andaging-project.aspx
https://simba.isr.umic
h.edu/data/data.aspx

Notes: In household interviews, a single family member from each household answers questions
on all individuals living in the same home. Only the MIDUS 3 random digit dial sample used.
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Table 2
Items About Dementia
Survey
BRFSS
HRS

Variable Name
Item
DECIDE
Because of a physical, mental, or emotional condition, do you have
serious difficulty concentrating, remembering, or making decisions?
OC272
Has a doctor ever told you that you have Alzheimer’s Disease?

Has a doctor ever told you that you have dementia, senility or any
other serious memory impairment?
NHANES
DLQ040
Because of a physical, mental, or emotional condition, {do you/does
he/does she} have serious difficulty concentrating, remembering, or
making decisions?
NHATS
hc4disescn9 Since the time of the last interview, has a doctor told you/SP that
you/SP had dementia or Alzheimer’s Disease?
NHIS
LAHCA16 What condition or health problem causes you to have difficulty with
{names of up to 3 specified activities/these activities}
NSHAP CONDITNS_83 Has a doctor ever told you that you have dementia, including
Alzheimer's disease, vascular dementia, mixed dementia, or Mild
Cognitive Impairment?
PSID
ER55293
(Has a doctor or other health professional EVER told [you / [HEAD /
ER56409
SP/WIFE]] that [you / he / she] had …) Permanent loss of memory or
loss of mental ability?
Notes: Affirmative (“Yes”) responses to these items, including if the condition was previously
OC273

mentioned in earlier years, indicated presence of dementia. For the NHIS item, presence of
dementia was indicated through a response of “senility.”
BRFSS = Behavioral Risk Factor Surveillance System; HRS = Health and Retirement Study;
NHANES = National Health and Nutrition Examination Survey; NHATS = National Health and
Aging Trends Survey; NHIS = National Health Interview Survey; NSHAP = National Social
Health and Aging Project; PSID = Panel Study of Income Dynamics. SP = Sample Person.
Head = Head of household.
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Table 3
Items About SCD

Study
HRS

MIDUS

Severity Point of Reference
Variable Name
Item
Response Options
D102
Compared to [[Previous Month], two 1. Better
years ago], would you say your/SP’s 2. Same
memory is better now, about the
3. Worse
same, or worse now than it was
then?
C1SA6E

Compared to five years ago, how
would you rate yourself today on

1. Improved a lot

2. Improved a little
3. Stayed the same
4. Gotten a little worse
5. Gotten a lot worse
NHATS cg4memcom1yr Compared to 1 year ago, would
1. Much better
you say your memory is much better 2. Better
now, better now, about the same,
3. Same
worse now, or much worse now than 4. Worse
it was then?
5. Much worse
Frequency Point of Reference
Over the past 7 days, how often have 1. Never
you/they? had trouble remembering 2. About once
where you/they put things, like
3. Two or three times
your/their keys or your/their wallet? 4. Nearly every day
5. Several times a day
NHATS cg4ofmemprob In the last month, how often did
1. Every day (7 days a week)
memory problems interfere with
2. Most days (5-6 days a week)
your daily activities? Would you say 3. Somedays (2-4 days a week)
every day, most days, some days,
4. Rarely (once a week or less)
rarely, or never?
5. Never
Notes: HRS = Health and Retirement Study; MIDUS = Midlife in the United States Study;
NHANES MCQ380

NHATS = National Health and Aging Trends Survey; NHANES = National Health and Nutrition
Examination Survey. SP = Sample person.
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Table 4
Pairwise Comparisons of Proportions of Older Adults with Reported Dementia
Study

BRFSS NHANES NHATS
PSID
HRS
NSHAP
NHIS
% (SE)
% (SE)
% (SE)
% (SE)
% (SE)
% (SE)
% (SE)
9.86
9.82
7.27
6.30
4.10
3.26
2.68
(0.17)
(0.67)
(0.42)
(0.74)
(0.20)
(0.48)
(0.15)
NHANES
0.035
0.051
0.959
NHATS
2.592
2.556
5.734
3.229
<0.001
0.001
PSID
3.554
3.518
0.962
4.665
3.513
1.127
<0.001
<0.001
0.260
HRS
5.762
5.726
3.170
2.208
21.984
8.169
6.808
2.868
<0.001
<0.001
<0.001
0.004
NSHAP
6.695
6.559
4.002
3.041
0.833
13.014
7.958
6.291
3.442
1.606
<0.001
<0.001
<0.001
<0.001
0.108
NHIS
7.174
7.139
4.582
3.620
1.413
0.579
31.496
10.363
10.248
4.771
5.567
1.153
<0.001
<0.001
<0.001
<0.001
<0.001
0.249
Notes: Table figures are rounded to the thousandths place; calculations were not rounded. In
order from top to bottom, each cell contains absolute difference, z-value, and pvalue. Bonferroni-corrected significant pairwise differences are indicated with bold text.
BRFSS = Behavioral Risk Factor Surveillance System; NHANES = National Health and
Nutrition Examination Survey; NHATS = National Health and Aging Trends Survey; PSID =
Panel Study of Income Dynamics; HRS = Health and Retirement Study; NSHAP = National
Social Health and Aging Project; NHIS = National Health Interview Survey. SE = Standard
error.
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Table 5
Proportion of Older Adults with Reported Dementia Across Studies
Demographic
BRFSS
NHANES
NHATS
Variable
% (95% CI)
% (95% CI )
% (95% CI )
Overall
9.9 (9.5, 10.2)
9.8 (8.5, 11.3)
7.3 (6.5, 8.2)
Age 65-74
9.1 (8.7, 9.6)
8.2 (6.6, 10.2)
2.2 (1.6, 3.0)
Age 75-84 10.8 (10.3, 11.4)
12.3 (10.0, 15.0)
7.6 (6.3, 9.1)
a
a
18.1 (15.6, 20.9)
Age 85+
NA
NA
Sex
Male
9.2 (8.8, 9.7)
7.9 (5.5, 11.4)
6.6 (5.5, 7.8)
Female
10.4 (9.9, 10.8)
11.3 (9.5, 13.4)
7.8 (6.8, 9.0)
Race
White
8.7 (8.4, 8.9)
9.4 (8.0, 11.1)
7.0 (6.1, 8.0)
Black
13.7 (12.4, 15.1)
8.6 (5.3, 13.7)
8.6 (6.9, 10.8)
Other
14.1 (12.5, 15.9)
13.0 (11.2, 15.1)
8.3 (5.8, 11.7)
Education
Less than
18.8 (17.6, 20.1)
15.9 (10.2, 23.9)
12.2 (10.2, 14.6)
I HS
HS
10.0 (9.5, 10.5)
9.5 (6.4, 14.0)
7.3 (5.9, 8.9)
College
6.9 (6.5, 7.3)
7.9 (6.1, 10.1)
5.2 (4.2, 6.5)
Notes: Percentages and confidence intervals are weighted.

PSID
% (95% CI )
6.3 (5.0, 8.0)
2.7 (1.6, 4.5)
5.8 (3.9, 8.5)
22.2 (16.8, 28.6)

HRS
% (95% CI )
4.1 (3.7, 4.5)
1.7 (1.4, 2.2)
5.2 (4.5, 6.0)
12.7 (11.0, 14.6)

NSHAP
% (95% CI )
3.3 (2.4, 4.4)
2.1 (1.3, 3.4)
4.1 (2.4, 6.9)
8.6 (5.5, 13.3)

NHIS
% (95% CI )
2.7 (2.4, 3.0)
0.9 (0.6, 1.1)
3.7 (3.1, 4.5)
8.9 (7.4, 10.7)

4.8 (3.5, 6.6)
7.5 (5.6, 10.0)

4.2 (3.7, 4.7)
4.0 (3.5, 4.6)

3.4 (2.1, 5.3)
3.2 (2.2, 4.6)

2.6 (2.1, 3.1)
2.8 (2.4, 3.2)

6.2 (4.8, 8.0)
7.4 (4.4, 12.3)
NAb

3.8 (3.4, 4.3)
6.6 (5.1, 8.5)
4.6 (2.7, 7.8)

3.4 (2.5, 4.7)
3.0 (1.4, 6.0)
2.1 (1.0, 4.5)

2.5 (2.2, 2.9)
4.0 (3.1, 5.1)
3.4 (2.3, 5.1)

10.5 (6.5, 16.4)

6.7 (5.6, 8.0)

4.2 (2.2, 7.6)

4.7 (3.8, 5.7)

7.4 (5.1, 10.7)
4.5 (3.2, 6.5)

3.9 (3.1, 4.8)
3.2 (2.9, 3.7)

2.4 (1.2, 4.8)
3.4 (2.5, 4.7)

2.6 (2.2, 3.1)
1.9 (1.6, 2.3)

BRFSS = Behavioral Risk Factor Surveillance System; NHANES = National Health and Nutrition Examination Survey; NHATS = National Health and
Aging Trends Survey; PSID = Panel Study of Income Dynamics; HRS = Health and Retirement Study; NSHAP = National Social Health and Aging Project;
NHIS = National Health Interview Survey. HS = High school. CI = Confidence Intervals.
a

Data on ages above 80 are not publicly available for BRFSS or NHANES; for those surveys this category represented age 75 + years.

b

Due to small sample size of “Other” in PSID, this category represents individuals who do not identify as white.
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Table 6
Pairwise Comparisons of Proportions of Older Adults with Reported SCD
Study

MIDUS
HRS
NHATS
% (SE)
% (SE)
% (SE)
46.56 (2.29)
24.34 (0.47)
13.01 (0.61)
HRS
22.219
9.51
<0.001
NHATS
33.549
11.330
14.159
14.646
<0.001
<0.001
Notes: Table figures are rounded to the thousandths place; calculations were not rounded. In
order from top to bottom, each cell contains absolute difference, z-value, and pvalue. Bonferroni-corrected significant pairwise differences are indicated with bold text.
MIDUS = Midlife in the United States Study; HRS = Health and Retirement Survey; NHATS =
National Health and Aging Trends Survey. SE = Standard Error.
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